$AAME

ATLANTIC AMERICAN CORP FY 2025: Revenue $210.4M, EPS $0.28— 10-K Summary

Atlantic American Corp reported FY 2025 revenue of $210.4M, up 11.9% YoY, and net income of $6.02M, reversing a prior-year loss. EPS was $0.28, driven by underwriting improvements, higher premiums, and investment gains. The company also disclosed a material weakness in premium receivable controls and restated 2024 figures.

Original reporting
Published Oct 16, 2026, 8:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 16, 2026, 8:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ATLANTIC AMERICAN CORP FY 2025: Revenue $210.4M, EPS $0.28— 10-K Summary — source image
Decision brief

The 30-second read

$AAMEBullishMed
01

Why it matters

The earnings beat could attract short‑term buying interest and a modest price rally.

02

Market read

Micro‑cap insurance stock with a fresh profit report, offering a potential short‑term upside.

03

What to watch

Net investment income and unrealized gains contributed to profitability, which may be less sustainable.

Relevance 6/10Novelty 7/10Timing: after-hours

Background

Atlantic American Corp filed its FY2025 10‑K, showing a turnaround to profitability after a loss in 2024.

Company-level read

Ticker impact

$AAMEBullishHigh confidence
Context

Atlantic American Corp posted FY2025 revenue of $210.4M and EPS of $0.28, reversing a loss and showing profitability for the first time.

Expected impact

likely upward pressure as the market prices in the earnings beat and profit reversal

Evidence & confidence

The company reported a profit after a prior loss, driven by higher premiums and investment gains, which is a material positive catalyst.

Market effects

Improved underwriting performance may signal strength in the P&C and Medicare Supplement segments.

Limited to U.S. insurance sector investors.

Low, as the company is a micro‑cap with niche exposure.

Counterpoint

The material weakness in premium receivable controls could pose future risk despite the earnings beat.

Key entities

  • Atlantic American Corp

    U.S. property & casualty insurer reporting FY2025 results.

Related articles

$PNFPHighAI 8/10

Pinnacle Financial Partners announces earnings for third quarter 2026

Pinnacle Financial Partners, Inc. (PNFP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Media Contact Investor Contact Joe Bass Samantha W. Tyagi 615-743-8219 404-364-2715 joe.bass@pnfp.com samantha.tyagi@synovus.com Pinnacle Financial Partners announces earnings for third quarter 2026 Diluted earnings per share of $2.40 versus $2.19 in 3Q25 Adjusted di

$THighAI 8/10

AT&T stock falls 6% despite earnings beat; SpaceX is the reason

AT&T's stock fell 6.3% despite beating Q3 earnings estimates and raising its 2026 profit outlook. Investors focused on wireless competition from SpaceX's Starlink Mobile. AT&T reported $32.3B revenue and 65 cents EPS, accelerating share buybacks to $10B. SpaceX's Starlink Mobile has 22M users, raising concerns about future competition.

$QCRHMed

What QCR (QCRH) Said on Its Q3 Earnings Call

QCR Holdings (QCRH) reported Q3 earnings, expecting to reprice $165M in loans and anticipating higher yields from municipal bonds. Non-interest income was $30M, with capital markets revenue rising to $17M. The company reaffirmed guidance and discussed strategies for LIHTC investments and regulatory capital management. Asset quality improved, and QCR repurchased 95,000 shares.

$DHRHighAI 8/10

Danaher Corp (DHR) (Q3 2026) Earnings Call Highlights: Core Growth Accelerates

Danaher Corp (DHR) reported Q3 2026 core revenue growth of 5.5%, but respiratory revenue was a 250 basis point headwind. The company expects full-year 2026 core revenue growth of 3%, with Q4 core growth excluding respiratory guided to 4-5%. CEO Julie Sawyer Montgomery emphasized commercial excellence and connected selling as key strategies. Bioprocessing orders grew mid-teens, and Masimo's integration is progressing well.

$IARTMed

Integra LifeSciences (IART) Reports Q3 Revenue In Line with Guid

Integra LifeSciences (IART) reported Q3 revenue of $411M, meeting the lower end of its guidance. The company lowered its full-year revenue outlook by $30M due to operational disruptions. IART's P/S ratio is 0.57, below historical and industry averages. The company has a GF Score of 69, indicating mixed fundamentals with strengths in momentum and profitability but weaknesses in growth and financial strength. Insider activity shows net buying of $0.1M, while institutional interest is mixed.

$LADHighAI 8/10

Lithia Motors (LAD) Q3 2026 Earnings Call Transcript

Lithia Motors (LAD) reported Q3 2026 earnings, with total vehicle GPU down $63 YoY but used vehicle GPU up 13%. North America SG&A improved 50 bps. Driveway Finance income rose 70% to $32M. Used vehicle gross profit grew 9.3%, while new vehicle revenues declined 2.6%. The company acquired four stores in Memphis, adding $250M in annualized revenue.